Statin use increases the risk of depressive disorder in stroke patients: A population-based study

Journal of the Neurological Sciences

Volumn 348, Issue 1-2, 2015, Pages 89-93

  Kang, Jiunn Horng ^a,b   Kao, Li Ting ^c   Lin, Herng Ching ^a,d   Tsai, Ming Chieh ^d,e   Chung, Shiu Dong ^a,f,g  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e CATHAY GENERAL HOSPITAL   (Taiwan)

^f FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^g FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Cerebrovascular disease; Depression; Depressive disorder; Epidemiology; Statin; Stroke

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; APHASIA; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HAZARD RATIO; HEMIPLEGIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STROKE PATIENT; TAIWAN; VERY ELDERLY; CHEMICALLY INDUCED; DEPRESSIVE DISORDER; INCIDENCE; REGISTER; RISK; STROKE;

ADULT; AGED; AGED, 80 AND OVER; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; RISK; STROKE; TAIWAN;

EID: 84920973909     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.11.013     Document Type: Article

References (40)

1. B. Sadowitz, K.G. Maier, and V. Gahtan Basic science review: statin therapy - part I: the pleiotropic effects of statins in cardiovascular disease Vasc Endovascular Surg 44 2010 241 251
2. P.R. Hebert, J.M. Gaziano, K.S. Chan, and C.H. Hennekens Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials JAMA 278 1997 313 321
3. F. Taylor, M.D. Huffman, A.F. Macedo, T.H. Moore, M. Burke, and G. Davey Smith Statins for the primary prevention of cardiovascular disease Cochrane Database Syst Rev 2013 CD004816
4. M.W. Russo, M. Scobey, and H.L. Bonkovsky Drug-induced liver injury associated with statins Semin Liver Dis 29 2009 412 422
5. S.W. Finks, and J.D. Campbell Avoiding patient morbidity: updated statin drug interactions and risks for patient harm Nurse Pract. 39 2014 45 51
6. E. Ikonen Cellular cholesterol trafficking and compartmentalization Nat Rev Mol Cell Biol 9 2008 125 138
7. E. Lloyd-Evans, and F.M. Platt Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease Traffic 11 2010 419 428
8. H. You, W. Lu, S. Zhao, Z. Hu, and J. Zhang The relationship between statins and depression: a review of the literature Expert Opin Pharmacother 14 2013 1467 1476
9. M. Tuccori, F. Lapi, A. Testi, D. Coli, U. Moretti, and A. Vannacci Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting Drug Saf 31 2008 1115 1123
10. L.R. Wagstaff, M.W. Mitton, B.M. Arvik, and P.M. Doraiswamy Statin-associated memory loss: analysis of 60 case reports and review of the literature Pharmacotherapy 23 2003 871 880
11. M.T. Hyyppä, E. Kronholm, A. Virtanen, A. Leino, and A. Jula Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial Psychoneuroendocrinology 28 2003 181 194
12. M. Tatley, and R. Savage Psychiatric adverse reactions with statins, fibrates and ezetimibe: implications for the use of lipid-lowering agents Drug Saf 30 2007 195 201
13. I. Mansi, C.R. Frei, M.J. Pugh, and E.M. Mortensen Psychologic disorders and statin use: a propensity score-matched analysis Pharmacotherapy 33 2013 615 626
14. E.M. Whyte, and B.H. Mulsant Post stroke depression: epidemiology, pathophysiology, and biological treatment Biol Psychiatry 52 2002 253 264
15. P.R. Hebert, D. Evans, W.R. Schneider, E. Rodriquez-Paz, and C.H. Hennekens The need for increased utilization of statins after occlusive stroke J Cardiovasc Pharmacol Ther 16 2011 364 367
16. J.M. Kim, R. Stewart, H.J. Kang, K.Y. Bae, S.W. Kim, and I.S. Shin A prospective study of statin use and poststroke depression J Clin Psychopharmacol 34 2014 72 79
17. Y.C. Chen, H.Y. Yeh, J.C. Wu, I Haschler, T.J. Chen, and T. Wetter Taiwan's National Health Insurance Research Database: administrative health care database as study object in bibliometrics Scientometrics 86 2011 365 380
18. J.H. Kang, Y.H. Chen, and H.C. Lin Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study Ann Rheum Dis 69 2010 1165 1168
19. C.L. Cheng, Y.H. Kao, S.J. Lin, C.H. Lee, and M.L. Lai Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan Pharmacoepidemiol Drug Saf 20 2011 236 242
20. M.F. Muldoon, S.B. Manuck, and K.A. Matthews Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials BMJ 301 1990 309 314
21. H. Engelberg Low serum cholesterol and suicide Lancet 339 1992 727 729
22. A. Khalid, N. Lal, J.K. Trivedi, P.K. Dalal, and O.P. Asthana Serum lipids: new biological markers in depression? Indian J Psychiatry 40 1998 217 223
23. S. Aijänseppä, P. Kivinen, E.L. Helkala, S.L. Kivelä, J. Tuomilehto, and A. Nissinen Serum cholesterol and depressive symptoms in elderly Finnish men Int J Geriatr Psychiatry 17 2002 629 634
24. M.L. Ancelin, I. Carrière, J.P. Boulenger, A. Malafosse, R. Stewart, and J.P. Cristol Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly (the ESPRIT study) Biol Psychiatry 68 2010 125 132
25. J.M. Kim, R. Stewart, S.W. Kim, I.S. Shin, S.J. Yang, and J.S. Yoon Cholesterol and serotonin transporter polymorphism interactions in late-life depression Neurobiol Aging 32 2011 336 343
26. N. Ruljancic, M. Mihanovic, and I. Cepelak Thrombocyte serotonin and serum cholesterol concentration in suicidal and non-suicidal depressed patients Prog Neuropsychopharmacol Biol Psychiatry 35 2011 1261 1267
27. C.Y. Fang, B.L. Egleston, K.P. Gabriel, V.J. Stevens, P.O. Kwiterovich Jr., and L.G. Snetselaar Depressive symptoms and serum lipid levels in young adult women J Behav Med 36 2013 143 152
28. K. Morales, M. Wittink, C. Datto, S. DiFilippo, M. Cary, and T. TenHave Simvastatin causes changes in affective processes in elderly volunteers J Am Geriatr Soc 54 2006 70 76
29. J. Vevera, Z. Fisar, T. Kvasnicka, H. Zdenek, L. Stárková, and R. Ceska Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission Psychiatry Res 133 2005 197 203
30. J.V. Agostini, M.E. Tinetti, L. Han, G. McAvay, J.M. Foody, and J. Concato Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults J Am Geriatr Soc 55 2007 420 425
31. F.J. Al Badarin, J.A. Spertus, K.L. Gosch, D.M. Buchanan, and P.S. Chan Initiation of statin therapy after acute myocardial infarction is not associated with worsening depressive symptoms: insights from the Prospective Registry Evaluating Outcomes After Myocardial Infarctions: Events and Recovery (PREMIER) and Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) registries Am Heart J 166 2013 879 886
32. L. Feng, K.B. Yap, E.H. Kua, and T.P. Ng Statin use and depressive symptoms in a prospective study of community-living older persons Pharmacoepidemiol Drug Saf 19 2010 942 948
33. B. Sjögren, M.W. Hamblin, and P. Svenningsson Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors Eur J Pharmacol 552 2006 1 10
34. S. Shrivastava, T.J. Pucadyil, Y.D. Paila, S. Ganguly, and A. Chattopadhyay Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin(1A) receptors Biochemistry 49 2010 5426 5435
35. T.J. Pucadyil, and A. Chattopadhyay Role of cholesterol in the function and organization of G-protein coupled receptors Prog Lipid Res 45 2006 295 333
36. A. Linetti, A. Fratangeli, E. Taverna, P. Valnegri, M. Francolini, and V. Cappello Cholesterol reduction impairs exocytosis of synaptic vesicles J Cell Sci 123 2010 595 605
37. M. Maes, I. Mihaylova, M. Kubera, M. Uytterhoeven, N. Vrydags, and E. Bosmans Lower plasma coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness Neuro Endocrinol Lett 30 2009 462 469
38. C.E. Kosmas, H. Alkhawam, M. El-Hunjul, G. Wagman, M.R. Kahn, and K.M. Grady Statin-mediated low-density lipoprotein lowering in chronic congestive heart failure Am J Med Sci 347 2014 14 22
39. S. Paolucci Epidemiology and treatment of post-stroke depression Neuropsychiatry Dis Treat 4 2008 145 154
40. A.J. Carson, S. MacHale, K. Allen, S.M. Lawrie, M. Dennis, and A. House Depression after stroke and lesion location: a systematic review Lancet 356 2000 122 126